Abbott (NYSE:ABT) today announced that the Government of Quebec's Régie de l'assurance maladie du Québec (RAMQ) publish...

 Cadrenal Therapeutics, Inc., (NASDAQ:CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vi...

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $14...

Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-d...

This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. ...